Managing the Complexities of Global Pharmaceutical Sourcing


Managing the Complexities of Global Pharmaceutical Sourcing

With the increased globalization and complexity of the pharmaceutical supply chain, managing the sourcing of materials has become extremely challenging. Reducing time costs are important goals of sourcing, but increased regulations and more rigorous enforcement make these goals difficult to achieve. In fact in a recent Price Waterhouse Coopers study, 50% of pharmaceutical executives surveyed view raw materials sourced outside of the U.S. the greatest vulnerability in the supply chain.


These trends have forced life science industry companies to optimize sourcing activities for raw materials, intermediates, active pharmaceutical ingredients (APIs) and other material components for clinical supplies and commercial manufacturing. In this challenging environment, companies are increasingly relying on highly qualified contract development and manufacturing organizations (CDMOs) to effectively manage the sourcing role.


Author: DPT

Find more white papers on Operational Excellence & Lean Six Sigma

View all white papers»